One-Carbon Metabolism (Folate Cycle)
- Compartment
- Cytosol + mitochondrion
- Main tissue
- All cells; esp. proliferating tissue
- Rate-limiting
- Thymidylate synthase (TYMS); GAR transformylase (GART)
- Steps
- 10
Reaction steps
In source order, 10 total
-
1
Dihydrofolate (DHF) + NADPH + H⁺ → tetrahydrofolate (THF) + NADP⁺
› Notes
Dihydrofolate reductase (DHFR) regenerates reduced THF after DHF is produced by thymidylate synthase. NADPH is required; this is an essential, effectively irreversible reductive regeneration step and the pharmacologic target of methotrexate, trimethoprim, and pyrimethamine.
-
2
L-serine + THF ⇌ glycine + 5,10-methylene-THF + H₂O
› Notes
Serine hydroxymethyltransferase (SHMT1 cytosolic; SHMT2 mitochondrial) uses PLP (vitamin B6) to transfer the serine β-carbon to THF. This reversible reaction is a major source of 5,10-methylene-THF.
-
3
5,10-Methylene-THF + NADP⁺ ⇌ 5,10-methenyl-THF + NADPH + H⁺
› Notes
The dehydrogenase activity of cytosolic trifunctional MTHFD1 (or mitochondrial MTHFD2/MTHFD2L) interconverts these folate species. Cofactor preference is enzyme- and compartment-specific; MTHFD1 uses NADP⁺, whereas mitochondrial MTHFD2 commonly uses NAD⁺.
-
4
5,10-Methenyl-THF + H₂O ⇌ 10-formyl-THF
Out 10-Formyl-THF› Notes
The cyclohydrolase activity of MTHFD1 (or mitochondrial MTHFD enzymes) converts the methenyl to the formyl oxidation state. This reversible hydration supplies 10-formyl-THF for purine biosynthesis.
-
5
THF + formate + ATP ⇌ 10-formyl-THF + ADP + Pᵢ
› Notes
10-Formyl-THF synthetase activity of MTHFD1 activates formate onto THF. ATP is consumed; in the direction of formate incorporation this is an essentially irreversible, energy-coupled reaction.
-
6
5,10-Methylene-THF + dUMP → dTMP + DHF
› Notes
Thymidylate synthase transfers and reduces a one-carbon unit to form dTMP, generating DHF. This is the committed one-carbon donation step for de novo thymidylate synthesis and is effectively irreversible; THF must be regenerated by DHFR for sustained DNA synthesis.
-
7
10-Formyl-THF + glycinamide ribonucleotide (GAR) → formyl-GAR + THF
› Notes
GAR transformylase (the phosphoribosylglycinamide formyltransferase domain of GART) donates one formyl group during de novo purine synthesis. This reaction is a committed folate-dependent input into the purine pathway after early purine assembly has begun.
-
8
10-Formyl-THF + AICAR → formyl-AICAR + THF
› Notes
AICAR transformylase (ATIC) donates the second formyl group required for inosine monophosphate synthesis. This reaction is followed by cyclization to IMP by the IMP cyclohydrolase activity of ATIC.
-
9
5,10-Methylene-THF + NADPH + H⁺ → 5-methyl-THF + NADP⁺
Methylenetetrahydrofolate reductase (MTHFR) 1.5.1.20 ST-0168 Irreversible NADP+ NADPH FAD THF (folate)› Notes
Methylenetetrahydrofolate reductase (MTHFR) uses FAD as a prosthetic group and NADPH-derived reducing power to generate 5-methyl-THF. This is an effectively irreversible, regulated branch-point reaction that commits one-carbon units to methionine regeneration rather than nucleotide synthesis.
-
10
5-Methyl-THF + homocysteine → THF + methionine
› Notes
Methionine synthase (5-methyltetrahydrofolate–homocysteine methyltransferase) requires methylcobalamin (vitamin B12) and transfers the methyl group through a cobalamin intermediate. The reaction regenerates THF and prevents trapping of cellular folate as 5-methyl-THF.
Showing all 10 steps.
Regulation
What speeds each enzyme up and what slows it down
MTHFR
S-adenosylmethionine deficiency/low methyl-group availability favors activity; FAD sufficiency
S-adenosylmethionine allosterically inhibits; folate/riboflavin deficiency reduces activity
Predominantly nutrient and allosteric regulation; insulin/growth signals influence one-carbon demand indirectly
DHFR
DHF accumulation and THF demand
Methotrexate; trimethoprim; pyrimethamine
No major acute hormonal regulation; expression rises with proliferative demand
Thymidylate synthase
dUMP and 5,10-methylene-THF availability
5-fluoro-dUMP (with reduced folate forms); folate deficiency
Upregulated with cell-cycle/proliferative signaling rather than a single systemic hormone
SHMT
Serine and THF availability; PLP sufficiency
PLP deficiency; product accumulation
Growth and nutritional state alter expression and mitochondrial one-carbon flux indirectly
Overview
The folate cycle uses tetrahydrofolate (THF) derivatives to carry and distribute one-carbon units at oxidation states ranging from methyl to formyl. These units support de novo purine synthesis, dTMP synthesis, methionine regeneration, serine/glycine interconversion, histidine catabolism, and formylation of initiator methionyl-tRNA in mitochondria. The cycle is particularly important in rapidly dividing tissues because nucleotide synthesis depends on 5,10-methylene-THF and 10-formyl-THF.
Cellular location
Folate-mediated one-carbon metabolism operates in both cytosol and mitochondria, with compartment-specific folate pools linked by export of one-carbon units such as formate. Cytosolic reactions are crucial for nucleotide synthesis and remethylation of homocysteine; mitochondrial serine catabolism supplies much of the one-carbon flux in proliferating cells. High flux occurs in liver, bone marrow, intestinal epithelium, placenta, and other tissues with active proliferation or methyl-group demand.
Net energetics
The folate cycle has no universal single net stoichiometry because THF carries one-carbon units among several linked pathways. Regeneration of THF from DHF costs 1 NADPH per DHF, formation of 10-formyl-THF from formate costs 1 ATP, and reduction of 5,10-methylene-THF to 5-methyl-THF consumes 1 NADPH equivalent. One 5,10-methylene-THF is oxidized to DHF for each dTMP formed, whereas two 10-formyl-THF molecules are used per IMP synthesized.
Clinical significance
Folate deficiency impairs dTMP and purine synthesis, producing defective DNA replication and megaloblastic anemia, particularly in bone marrow. Vitamin B12 deficiency impairs methionine synthase, causes methyl-folate trapping and functional folate deficiency, and also produces neurologic disease through mechanisms not corrected by folate alone. Antifolate drugs exploit the dependence of rapidly proliferating cells or microorganisms on DHFR and folate-dependent nucleotide synthesis; excessive folate supplementation can partially correct anemia while masking hematologic evidence of B12 deficiency.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
AMD1-mediated polyamine metabolism governs tubular repair fate by restraining senescence after kidney injury.
Mao B, Zheng Z, Fu W, Cheng G, Wang L, Bao J, Liu X, Zhan H, Pan M, Liu J. · 2026-06-14
open access unreviewed -
2
Recent advances and clinical relevance of microbiome dynamics in health and disease.
Gavanji S, Suhail M, Bencurova E, Dandekar T, Othman EM. · 2026-06-12
open access unreviewed -
3
Significance of GSH and H<sub>2</sub>S regulation for cancer: an intricate interplay between diet, microbiota, metabolic reprogramming, and immune health.
Majumder A, Majumder S, Bano S, Sen K, Nayak KB. · 2026-06-11
open access unreviewed -
4
The regulatory roles of non-coding RNAs in aerobic glycolysis and therapeutic potential in pancreatic ductal adenocarcinoma.
Fan Y, Tang X, Li S, Liu S, Fang Y, Sun X, Xue Z, Niu H, Chen Y, Dai C, Ling R. · 2026-06-09
open access unreviewed -
5
Microbiome functional gene pathways are indicative of cognitive performance in older adults at risk for Alzheimer's disease.
Zeamer AL, Lai Y, Loew E, Sanborn V, Tracy M, Jo C, Ferdinand D, Ward DV, Bhattarai SK, Drake J, McCormick BA… · 2026-05-24
open access unreviewed -
6
The gut-bone axis: microbial metabolism and nutritional interventions for bone health.
Rodriguez-Bryant A, Papageorgiou M, Horcajada MN, Biver E, Ferrari S, Bonnet N. · 2026-05-22
cited 1× open access unreviewed -
7
Parental microbiome programming of early-life neurodevelopment: multi-niche contributions through the microbiome-gut-brain axis.
Skrabulyte-Barbulescu J, Yassin LK, Almazrouei S, Alkuwaiti SH, Almarzooqi S, Alnuaimi F, Alketbi S, Nakhal M… · 2026-05-14
open access unreviewed -
8
Gut microbiota and immunometabolism in obesity.
Torres-Mayo A, Liébana-García R, Olivares M, Pellón A, Anguita J, Sanz Y. · 2026-05-05
cited 1× open access unreviewed -
9
Gut microbiota and diet in colorectal cancer: Converging determinants of carcinogenesis.
Thakur BK, Choudhury SR, Turpin W, Martin A. · 2026-05-04
open access unreviewed -
10
Microbiome signatures correlate with diet-mediated ADHD symptom reduction.
Hontelez S, Guthrie M, Stobernack T, van Baarlen P, Rousseau C, Boks MP, Pereira RR, Boekhorst J, Kleerebezem… · 2026-04-16
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.